Chemours Files 8-K: Other Events Notification

Ticker: CC · Form: 8-K · Filed: 2025-09-03T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, regulatory-filing

Related Tickers: CC

TL;DR

Chemours filed an 8-K for 'Other Events' - no big numbers, just an update.

AI Summary

On September 2, 2025, The Chemours Company filed an 8-K report detailing "Other Events." The filing does not contain specific financial figures or new material agreements but serves as a notification of events relevant to the company's operations and reporting obligations.

Why It Matters

This filing indicates that Chemours has reported events requiring public disclosure, which could include operational updates, regulatory matters, or other significant corporate actions.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for 'Other Events' and does not disclose any immediate financial risks or significant negative developments.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by The Chemours Company in this 8-K filing?

The provided excerpt of the 8-K filing does not specify the details of the 'Other Events'; it only indicates that this section is being reported.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is September 2, 2025.

What is The Chemours Company's principal executive office address?

The Chemours Company's principal executive office is located at 1007 Market Street, Wilmington, Delaware 19801.

Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?

This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the Commission File Number for The Chemours Company's 8-K filing?

The Commission File Number for this filing is 001-36794.

From the Filing

0000950170-25-112670.txt : 20250903 0000950170-25-112670.hdr.sgml : 20250903 20250903065034 ACCESSION NUMBER: 0000950170-25-112670 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20250902 ITEM INFORMATION: Other Events FILED AS OF DATE: 20250903 DATE AS OF CHANGE: 20250903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 251287710 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20250902.htm 8-K 8-K false 0001627223 0001627223 2025-09-02 2025-09-02     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   September 2, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐           Item 8.01 Other Events.   The Chemours Company (the “Company”) announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act.                       SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     THE CHEMOURS COMPA

View on Read The Filing